Subscribe To
Intercept pharmaceuticals stock tumbles toward 11-month low after disappointing fda committee vote
Shares of Intercept Pharmaceuticals Inc. ICPT, -1.95% tumbled 15.2% toward an 11-month low in premarket trading Monday, after the biopharmaceutical co...
May 22, 2023, 7:38 am
A perfect storm in pharmacotherapy: the opportunity to invest in nash
NASH, or nonalcoholic steatohepatitis, is a liver inflammatory disease that can progress to fibrosis an...
March 29, 2023, 11:40 pm
Biotech stock surges on mid-stage drug trial success
The shares of 89bio Inc ( NASDAQ:ETNB) are up 38.2% to trade at $15.11 at last check, after the biotech name revealed its experimental drug pegozaf...
March 22, 2023, 10:49 am
Kotak institutional equities downgrades nalco citing unfavourable risk-reward
The capex for the alumina refinery may also result in nalco seeing negative free cashflow over a simila...
January 12, 2023, 5:44 am
Madrigal (mdgl) soars as resmetirom meets goal in nash study
Madrigal's (MDGL) phase III MAESTRO-NASH study evaluating resmetirom for treating nonalcoholic steatohe...
December 20, 2022, 12:47 pm
Madrigal’s stock rallies about 200% after sharing positive data about its nash treatment candidate
Shares of Madrigal Pharmaceuticals Inc. soared 209.6% in premarket trading on Monday after the company shared positive data from a pivotal Phase 3 cli...
December 19, 2022, 1:07 pm
Why madrigal pharmaceuticals stock is crushing it today
The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic ...
December 19, 2022, 11:50 am
Madrigal pharmaceuticals shares soar on positive trial results for its nash and liver fibrosis drug resmetirom
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) shares have soared more than 250% after the biopharmaceutical company shared positive topline results from ...
December 19, 2022, 10:41 am
Why is madrigal pharmaceuticals (mdgl) stock up 216% today?
Madrigal Pharmaceuticals (NASDAQ: MDGL ) stock is rocketing higher on Monday after sharing results from its novel therapeutics for no...
December 19, 2022, 9:48 am
Madrigal's stock rallies about 200% after sharing positive data about its nash treatment candidate
Shares of Madrigal Pharmaceuticals Inc. MDGL, +1.43% soared 209.6% in premarket trading on Monday after the company shared positive data from a pivota...
December 19, 2022, 8:07 am
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nash study of resmetirom on monday, december 19th
CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursui...
December 18, 2022, 9:00 pm
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nash study of resmetirom on monday, december 19th
CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...
December 18, 2022, 4:00 pm
Altimmune appears to have a winner, but will the market believe?
On September 14, shares plummeted 27% on topline results from a Phase 1 study of pemvidutide. Reductions in liver fat appear to be substantially bette...
December 2, 2022, 10:19 am